PuraMed BioScience Announces LipiGesic M Now Available at Walgreens

PuraMed BioScience, Inc. (OTC: PMBS) announced today that their new non-prescription migraine medication, LipiGesic™ M, is now available for sale nationwide at the number one chain of drugstores in the United States, Walgreens. Walgreens, with its over 7,700 locations is the nation's largest drugstore chain and is the only chain to operate in all 50 states as well as the District of Columbia and Puerto Rico. PuraMed BioScience CEO, Russ Mitchell, stated, "We continue to execute our expansion strategy to seek strong penetration in mass retail channels, and now with distribution in Walgreens, our LipiGesic™ M product is even more accessible to the more than 50 million migraine sufferers in the U.S. alone."